Norovirus is the leading cause of gastroenteritis and is responsible for hundreds of thousands of deaths every year. However, research progress into antiviral treatments and vaccines has been hindered by the absence of a ...
Dec 10, 2025
0
0
Idiopathic pulmonary fibrosis (IPF) is a chronic disease in which healthy lung tissue is gradually replaced by scar tissue. While the early events that initiate this change are poorly understood, recent research suggests ...
Dec 10, 2025
0
0
Friedreich's ataxia (FA) is a rare but devastating genetic disorder. Those with the condition are often diagnosed between 5 and 15 years of age and live only into their 30s or 40s. There is no widely approved treatment that ...
Dec 10, 2025
0
21
Northwestern University scientists have potentially uncovered a previously unknown, hidden player in pneumonia. In a new study, scientists found the lungs' own microbial community, or microbiome, appears to influence how ...
Dec 10, 2025
0
1
A single signaling pathway controls whether immune cells attack or befriend cells they encounter while patrolling our bodies, researchers at Stanford Medicine have found. Manipulating this pathway could allow researchers ...
Dec 10, 2025
0
15
Older people with a history of chronic kidney disease or conditions affecting blood flow to the brain such as stroke face about double the risk of developing neuroinvasive disease that can lead to paralysis and death following ...
Dec 10, 2025
0
0
An infection with respiratory syncytial virus (RSV) typically affects infants much harder than adults. While adults usually experience RSV as a mild cold, infants can develop more severe conditions, including life-threatening ...
Dec 9, 2025
0
0
In a major step toward a precision therapy for Clostridioides difficile (C. diff) infection, researchers at The Hospital for Sick Children (SickKids) have uncovered how the body's bile acids bind to block C. diff's most dangerous ...
Dec 9, 2025
0
1
More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary immune thrombocytopenia (ITP), an autoimmune disorder that can cause life-threatening ...
Dec 9, 2025
0
49
Immunotherapy for sepsis is effective when doctors tailor the treatment precisely to the patient's immune system condition. While earlier research showed little benefit of immunotherapy in sepsis, a new study demonstrates ...
Dec 8, 2025
0
19
